Sign in

CIK 0001425205

  • Accelerated filer

IOVANCE BIOTHERAPEUTICS, INC.

Sign in to watch
Ticker
IOVA
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
753254381
Phone
+1 650-260-7120
Business address
825 INDUSTRIAL ROAD, 4TH FLOOR, SAN CARLOS, CA, 94070
Former names
Lion Biotechnologies, Inc., Genesis Biopharma, Inc, FREIGHT MANAGEMENT CORP
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 99 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2026-06-16 Maynard Ryan D Director Grant or award · Deferred Restricted Stock Unit +90,316 90,316
2025-06-13 Maynard Ryan D Director Grant or award · Deferred Restricted Stock Unit +67,546 67,546
2024-11-12 Maynard Ryan D Director Option exercise +50,000 $7.45 $373K 57,500
2024-11-12 Maynard Ryan D Director Sale −50,000 $10.06 $503K 7,500
2024-11-12 Maynard Ryan D Director Option exercise · Stock Option (right to buy) −50,000 0
2024-06-11 Maynard Ryan D Director Grant or award · Deferred Restricted Stock Unit +49,303 49,303
2024-03-01 Maynard Ryan D Director Grant or award · Deferred Restricted Stock Unit +50,000 50,000
2023-06-06 Maynard Ryan D Director Grant or award · Deferred Restricted Stock Unit +51,955 51,955
2022-06-10 Maynard Ryan D Director Grant or award · Deferred Restricted Stock Unit +51,204 51,204
2022-05-31 Maynard Ryan D Director Purchase +7,500 $6.75 $51K 7,500
2021-06-29 Maynard Ryan D Director Grant or award · Stock Option (right to buy) +35,000 35,000
2020-06-08 Maynard Ryan D Director Grant or award · Stock Option (right to buy) +35,000 35,000

Page 1 of 1 · 12 trades